| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new mechanism of resistance to ABL1 tyrosine kinase inhibitors in a BCR-ABL1-positive cell line
|
Airiau, Kelly
|
|
2017
|
61 |
C |
p. 44-52
|
artikel
|
| 2 |
A phase 1 study of the Janus kinase 2 (JAK2)V617F inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential thrombocythemia
|
Verstovsek, Srdan
|
|
2017
|
61 |
C |
p. 89-95
|
artikel
|
| 3 |
DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia
|
Younesian, Samareh
|
|
2017
|
61 |
C |
p. 33-38
|
artikel
|
| 4 |
Editorial board and publication information
|
|
|
2017
|
61 |
C |
p. IFC
|
artikel
|
| 5 |
Establishment of cell line with NK/NKT phenotype from myeloid NK cell acute leukemia
|
Darji, A.
|
|
2017
|
61 |
C |
p. 77-83
|
artikel
|
| 6 |
HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia
|
Caocci, Giovanni
|
|
2017
|
61 |
C |
p. 1-5
|
artikel
|
| 7 |
Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia/lymphoma
|
Sakihama, Shugo
|
|
2017
|
61 |
C |
p. 18-24
|
artikel
|
| 8 |
Inhibition of c-REL using siRNA increased apoptosis and decreased proliferation in pre-B ALL blasts: Therapeutic implications
|
Mohammadi, Seyedeh Momeneh
|
|
2017
|
61 |
C |
p. 53-61
|
artikel
|
| 9 |
Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy
|
Comont, Thibault
|
|
2017
|
61 |
C |
p. 62-67
|
artikel
|
| 10 |
Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort study
|
Frairia, Chiara
|
|
2017
|
61 |
C |
p. 10-17
|
artikel
|
| 11 |
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
|
Webster, Jonathan A.
|
|
2017
|
61 |
C |
p. 108-116
|
artikel
|
| 12 |
Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification
|
Chen, Yan
|
|
2017
|
61 |
C |
p. 39-43
|
artikel
|
| 13 |
Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2
|
Fleischman, Roger A.
|
|
2017
|
61 |
C |
p. 104-107
|
artikel
|
| 14 |
Ruxolitinib for the management of myelofibrosis: Results of an international physician survey
|
Ellis, Martin H.
|
|
2017
|
61 |
C |
p. 6-9
|
artikel
|
| 15 |
TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.
|
Tamai, M.
|
|
2017
|
61 |
C |
p. 68-76
|
artikel
|
| 16 |
The high frequency of the U2AF1 S34Y mutation and its association with isolated trisomy 8 in myelodysplastic syndrome in Asians, but not in Caucasians
|
Kim, Seon Young
|
|
2017
|
61 |
C |
p. 96-103
|
artikel
|
| 17 |
The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia
|
Wang, Fang
|
|
2017
|
61 |
C |
p. 84-88
|
artikel
|
| 18 |
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
|
Norsworthy, Kelly J.
|
|
2017
|
61 |
C |
p. 25-32
|
artikel
|
Tijdschrift beschrijving